The Evidence Based Rheumatology Podcast
A podcast for physicians about evidence based medicine in rheumatology. Each week we'll critique and apply a paper in the medical literature.
- Update frequency
- every 13 days
- Average duration
- 15 minutes
- Episodes
- 102
- Years Active
- 2018 - 2025
E86: Target Trials and Causality in Rheumatology
Mixing it up again this week to discuss an editorial by Miguel Hernan and a systematic review of target trials in rheumatology. It's kind of a fun free-form stream of consciousness. Hope you enjoy! L…
E85: Challenging Wisely
Quick episode today. I wanted to share an editorial that was recently published in Rheumatology, where I and co-authors (Shannon Tai and Natalie Anumolu) discuss lessons from recent trials in AAV and…
E84: The JAKapocalypse (AKA ORAL Surveillance)
After some delay, I finally get around to discussing ORAL-Surveillance, a post-marketing safety study of tofacitinib for rheumatoid arthritis. It's an incredibly important trial that will likely affe…
E83: Effectiveness of COVID-19 Vaccines
After a winter hiatus, the podcast is back! Today I wanted to dive into a 'hotbutton' issue - the question of whether (or not) COVID-19 vaccines "work" for patients with rheumatic diseases. My answer…
E82: LoVAS Trial for ANCA Vasculitis
Hello again! Snappy episode this week about the exciting LoVAS trial, which compared a reduced dose steroid taper for ANCA vasculitis. Be sure to drop by my website at ebrheum.com to subscribe to my …
E81: Vasculitis Guidelines E7: Takayasu Arteritis with Dr. Andy Abril
In this episode, I talk with Dr. Andy Abril, Chair at the Division of Rheumatology at the Mayo Clinic in Jacksonville Florida. Dr. Abril is one of the lead authors for the 2021 ACR Guidelines on Ta…
E80: Vasculitis Guidelines E6 - Polyarteritis Nodosa with Dr. Jason Springer
In this episode, I talk with Dr. Jason Springer, Co-Director of the Vanderbilt Vasculitis Center, about the guidelines for PAN He is one of the lead authors for the ACR/VF Guidelines for Polyarterit…
E79: Vasculitis Guidelines E5 - GCA with Dr. Mehrdad Maz
On today's episode I discuss GCA with Dr. Mehrdad Maz. He is the Division Director of the Kansas University Allergy, Clinical Immunology and Rheumatology Section and served on the Steering Core Comm…
E78: Vasculitis Guidelines #4 - EGPA with Dr. Phil Seo
In today's episode, I talk with Dr. Mehrdad Maz about the newly published guidelines for giant cell arteritis (GCA). Dr. Maz is the Division Director of the Kansas University Allergy, Clinical Immun…
E77: Vasculitis Guidelines #3 - ANCA Vasculitis with Dr. Sharon Chung
The guidelines have finally arrived! I'm kicking off the series today with a conversation about the ANCA vasculitis guidelines. My guest is Dr. Sharon Chung, the director of the UCSF Vasculitis Cli…
E76: Voclosporin for SLE Nephritis: The AURORA RCT
Hopping in this week to round out my thoughts on ADVOCATE (avacopan in AAV) and covering the recently published AURORA trial for SLE nephritis. Back to the Vasculitis Guidelines Podcast after as soon…
E75: Vasculitis Guidelines Episode 2: Overview with Sharon Chung
In this episode we'll be introducing the process by which the 2021 ACR/VF guidelines were produced. My guest is Dr. Sharon Chung. She's the director of the UCSF Vasculitis Clinic and the lead inves…
E74: Vasculitis Guidelines Episode 1 - Joyce Kullman
Welcome to the first episode of the Vasculitis Guidelines Podcast! In Episode 1, I interview Joyce Kullman, Executive Director of the Vasculitis Foundation, about collaborating with the ACR in updat…
E73: Introducing the Vasculitis Guidelines Podcast
Quick update on a new series!
E72: Avacopan for ANCA Vasculitis
Steroid free remission! Or is it? This week I discuss a really exciting trial in ANCA vasculitis.
E71: MTX Discontinuation Post... Influenza Vaccination
I stole some time to tackle a pressing issue for rheumatologists - to hold or not to hold immunosuppression in patients who are receiving a COVID19 vaccination. We obviously don't have any data on t…
E70: Rheum4Debate - HCQ Levels Should Be Monitored in Patients with SLE
We have a great show for you this week! Anisha Dua will be moderating a debate
between myself and Max Konig on this motion: "Hydroxychloroquine levels should be monitored in patients with SLE." I …
E69: Publication Trends in SRMAs and RCTs
This week I cover another of my meta-research projects, this one on systematic review and meta analysis (SRMA) growth as compared to randomized clinical trial (RCT) growth. Short and to the point - …
E68: SELECT-CHOICE Upadacitinib vs Abatacept in RA
Active comparator trial! Always my favorite. Lots of fun topics in this one, including noninferiority trials, crafty endpoints, and PROs. Check it out and let me know what you think! @ebrheum
E67: Belimumab in Lupus Nephritis (BLISS-LN)
Another day, another lupus trial, another round of endpoint shenanigans. Why does that matter? How big is the benefit from belimumab in SLE nephritis? Will this save lives and prevent ESRD / RRT? I …